Published in Bull N Y Acad Med on March 01, 1987
Organ specificity of lymphocyte migration: mediation by highly selective lymphocyte interaction with organ-specific determinants on high endothelial venules. Eur J Immunol (1980) 3.80
Characteristics of mesenteric lymph node cells homing to gut-associated lymphoid tissue in syngeneic mice. J Immunol (1975) 1.84
Primary gastrointestinal non-Hodgkin's lymphomas. A retrospective clinicopathologic study of 150 cases. Cancer (1985) 1.67
Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD). J Clin Oncol (1983) 1.45
Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy. Ann Intern Med (1983) 1.23
Sequential nonsurgical and surgical staging of non-Hodgkin's lymphoma. Ann Intern Med (1976) 1.22
Role of radiation therapy in localized non-Hodgkin's lymphoma. Radiother Oncol (1985) 1.18
Chemotherapy of localised histiocytic lymphoma. Lancet (1979) 1.04
Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys (1980) 1.03
Ocular reticulum cell sarcoma. Clinicopathologic correlation of a case with multifocal lesions. Retina (1985) 0.96
Curability of gastrointestinal lymphoma with combined surgery and radiation. Int J Radiat Oncol Biol Phys (1983) 0.92
Pathogenesis of Osler's nodes. Ann Intern Med (1976) 0.87
Testicular lymphomas: a clinicopathologic study of 35 cases. Cancer (1981) 0.86
Radiation therapy in the management of primary malignant lymphoma of the brain. Int J Radiat Oncol Biol Phys (1981) 0.85
Lymphocytes and the gut. Digestion (1975) 0.81
Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol (1989) 5.44
The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer (1998) 1.65
Papillary and follicular thyroid cancer. Prognostic factors in 1,578 patients. Am J Med (1987) 1.54
Cytotoxic-induced ovarian failure in women with Hodgkin's disease. I. Hormone function. JAMA (1979) 1.52
MVPP chemotherapy regimen for advanced Hodgkin's disease. Br Med J (1978) 1.46
Analysis of supradiaphragmatic clinical stage I and II Hodgkin's disease treated with radiation alone. Int J Radiat Oncol Biol Phys (1992) 1.45
Thoracic radiation therapy before autologous bone marrow transplantation in relapsed or refractory Hodgkin's disease. PMH Lymphoma Group, and the Toronto Autologous BMT Group. Eur J Cancer (1999) 1.44
Role of radiation therapy in advanced Hodgkin's disease--as yet, an answer? Still a question? Ann Oncol (1992) 1.44
Acute transient parotitis after high dose etoposide and autologous bone marrow transplantation. Bone Marrow Transplant (1990) 1.40
Propranolol-induced hypoglycaemia and myocardial infarction. Br Med J (1972) 1.38
Cyclical combination chemotherapy and gonadal function. Retrospective study in males. Lancet (1979) 1.31
Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type. Br Med J (1978) 1.25
Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med (1992) 1.24
Post-treatment laparotomy in the management of Hodgkin's disease. Lancet (1978) 1.23
Male gonadal dysfunction in Hodgkin's disease. A prospective study. JAMA (1981) 1.21
Role of radiation therapy in localized non-Hodgkin's lymphoma. Radiother Oncol (1985) 1.18
Maternal and fetal outcome after breast cancer in pregnancy. Am J Obstet Gynecol (1992) 1.10
Papillary and follicular thyroid cancer: impact of treatment in 1578 patients. Int J Radiat Oncol Biol Phys (1988) 1.07
Localised lymphoma of bone: prognostic factors and treatment recommendations. The Princess Margaret Hospital Lymphoma Group. Br J Cancer (1992) 1.04
Intensive investigation in management of Hodgkin's disease. Br Med J (1976) 1.04
Patterns of disease in localized extranodal lymphomas. J Clin Oncol (1987) 1.03
Radiotherapy in the treatment of Hodgkin's disease. Br Med J (1978) 1.01
Protection of ovarian function by oral contraceptives in women receiving chemotherapy for Hodgkin's disease. Blood (1981) 0.98
Cytotoxic-induced ovarian failure in Hodgkin's disease. II. Effects on sexual function. JAMA (1979) 0.96
Non-Hodgkin's lymphoma of the thyroid gland: prognostic factors and treatment outcome. The Princess Margaret Hospital Lymphoma Group. Int J Radiat Oncol Biol Phys (1993) 0.95
Adriamycin, bleomycin, vinblastine and imidazole carboxamide (ABVD) therapy for advanced Hodgkin's disease resistant to mustine, vinblastine, procarbazine and prednisolone (MVPP). Cancer Chemother Pharmacol (1979) 0.95
Prognostic groups for management of localized Hodgkin's disease. J Clin Oncol (1985) 0.94
Localized extradural lymphoma: survival, relapse pattern and functional outcome. The Princess Margaret Hospital Lymphoma Group. Radiother Oncol (1992) 0.94
Maternal and foetal outcome following Hodgkin's disease in pregnancy. Br J Cancer (1992) 0.94
Cyclical combination chemotherapy and thyroid function in patients with advanced Hodgkin's disease. Med Pediatr Oncol (1981) 0.89
Role of radiation therapy in clinical hormonally-active pituitary adenomas. Radiother Oncol (1996) 0.89
Computerised tomographic (CT) abdominal scanning in Hodgkin's disease. Clin Radiol (1980) 0.88
Maternal and fetal outcome after invasive cervical cancer in pregnancy. J Clin Oncol (1991) 0.87
Peripheral neuropathy following high-dose etoposide and autologous bone marrow transplantation. Bone Marrow Transplant (1994) 0.86
Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease before intensive therapy and autologous bone marrow transplantation. J Clin Oncol (1995) 0.86
The effects of dialyzable products from human leukocyte extracts on cutaneous delayed-hypersensitivity response. J Immunol (1980) 0.85
The role of intensive therapy and autologous blood and marrow transplantation for chemotherapy-sensitive relapsed and primary refractory non-Hodgkin's lymphoma: identification of major prognostic groups. Br J Haematol (1996) 0.85
Radiation therapy for pituitary adenoma: treatment outcome and prognostic factors. Int J Radiat Oncol Biol Phys (1994) 0.85
Treatment of neoplastic disease during pregnancy: maternal and fetal effects. Clin Invest Med (1985) 0.85
Non-Hodgkin's lymphoma and pregnancy. Leuk Lymphoma (1994) 0.85
Posttreatment laparotomy as a guide to management in patients with Hodgkin's disease. Cancer Treat Rep (1982) 0.83
Magnetic resonance imaging of the prostate. Radiology (1985) 0.83
Hodgkin's disease: combination chemotherapy for relapse following radical radiotherapy. Int J Radiat Oncol Biol Phys (1979) 0.82
Anaplastic large cell lymphoma: a clinicopathologic analysis. Hematol Oncol (1999) 0.82
Late effects of treatment for early-stage Hodgkin's disease. Br J Cancer (1998) 0.80
Late relapse after treatment for clinical stage I and II Hodgkin's disease. Cancer (1997) 0.80
Cytotoxic chemotherapy and gonadal function in patients with Hodgkin's disease. Facts and thoughts. JAMA (1979) 0.79
Evaluation of cytoreductive therapy prior to high dose treatment with autologous bone marrow transplantation in relapsed and refractory Hodgkin's disease. Bone Marrow Transplant (1990) 0.79
Reduction in the incidence of postradiation dental complications in cancer patients by continuous quality improvement techniques. Can J Oncol (1994) 0.78
The role of surgery in the management of thyroid lymphoma. Surgery (1988) 0.77
Cancer control: life and death in an unequal world. Curr Oncol (2012) 0.77
Radiation therapy in clinical stage I and II Hodgkin's disease. The Princess Margaret Hospital Lymphoma Group. Eur J Cancer (1992) 0.77
Outcome analysis of localized gastrointestinal lymphoma treated with surgery and postoperative irradiation. Int J Radiat Oncol Biol Phys (1990) 0.76
Mini-beam as salvage chemotherapy for refractory Hodgkin's disease and non-Hodgkin's lymphoma. Leuk Lymphoma (1991) 0.76
Public health aspects of breast cancer gene testing in Canada. Chronic Dis Can (1999) 0.75
In vivo modification of delayed type hypersensitivity by small molecular weight components derived from human leucocytes: partial purification of components causing amplification of response. Clin Exp Immunol (1982) 0.75
Transfer factor and immunity: an introduction. Ann N Y Acad Sci (1979) 0.75
Treatment of Hodgkin's disease. Baillieres Clin Haematol (1987) 0.75
MRI of periprostatic venous plexus in staging of early prostatic carcinoma. Can Assoc Radiol J (1988) 0.75
The management of stage IIIA Hodgkin's disease. Int J Radiat Oncol Biol Phys (1980) 0.75
Analysis of factors affecting hematopoietic recovery after autologous bone marrow transplantation for lymphoma. Bone Marrow Transplant (1990) 0.75
Heterogeneity in responses to cancer. Part II: Sexual responses. Can J Psychiatry (1991) 0.75
Influence of total body irradiation on infections after autologous bone marrow transplantation. Bone Marrow Transplant (1991) 0.75
GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation. Exp Hematol (1991) 0.75
Osteonecrosis after intensive chemotherapy for Hodgkin's disease. Lancet (1978) 0.75
Mediastinal involvement by Hodgkin's disease and the implications for management for those patients with local or loco-regional disease. Hematol Oncol (1984) 0.75
Prognosis of Hodgkin's disease: patients who fail to remit or who relapse after combination chemotherapy. Clin Oncol (1980) 0.75
The response of diffuse large cell and other intermediate grade non-Hodgkin's lymphomas to adriamycin containing combination chemotherapy. Leuk Lymphoma (1994) 0.75
Hodgkin's disease occurring during acute leukaemia in remission. Lancet (1977) 0.75
Thyroid damage--after treatment for Hodgkin's disease. Clin Oncol (1984) 0.75
Economic analysis of prophylactic G-CSF after mini-BEAM salvage chemotherapy for Hodgkin's and non-Hodgkin's lymphoma. Leuk Lymphoma (1995) 0.75
Magnetic resonance imaging, computed tomography, and radionuclide scintigraphy in detection of liver metastases. Can Assoc Radiol J (1988) 0.75
Heterogeneity in responses to cancer. Part I: Psychiatric symptoms. Can J Psychiatry (1991) 0.75
Staging in Hodgkin's disease. Clin Haematol (1979) 0.75
Initiation of blast crisis of chronic myeloid leukaemia in extramedullary sites. Clin Oncol (1981) 0.75